iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Large Volume Increase – What’s Next?

by · The Cerbat Gem

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Free Report) shares saw strong trading volume on Tuesday . 211,873 shares traded hands during trading, an increase of 189% from the previous session’s volume of 73,205 shares.The stock last traded at $85.3660 and had previously closed at $84.05.

iShares U.S. Pharmaceuticals ETF Stock Up 0.1%

The company has a market capitalization of $691.66 million, a P/E ratio of 17.75 and a beta of 0.54. The company’s fifty day moving average price is $75.97 and its 200 day moving average price is $70.40.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. National Bank of Canada FI lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 42.7% during the 3rd quarter. National Bank of Canada FI now owns 585 shares of the company’s stock worth $42,000 after buying an additional 175 shares in the last quarter. Mercer Global Advisors Inc. ADV lifted its position in iShares U.S. Pharmaceuticals ETF by 115.0% in the third quarter. Mercer Global Advisors Inc. ADV now owns 8,311 shares of the company’s stock valued at $603,000 after purchasing an additional 4,446 shares during the last quarter. Focus Partners Wealth boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 16.0% during the third quarter. Focus Partners Wealth now owns 3,617 shares of the company’s stock valued at $263,000 after purchasing an additional 500 shares during the period. Ameriprise Financial Inc. grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 6.6% in the third quarter. Ameriprise Financial Inc. now owns 25,221 shares of the company’s stock worth $1,830,000 after purchasing an additional 1,563 shares during the last quarter. Finally, Creative Planning raised its holdings in iShares U.S. Pharmaceuticals ETF by 6.3% during the 3rd quarter. Creative Planning now owns 6,516 shares of the company’s stock valued at $473,000 after buying an additional 389 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Company Profile

(Get Free Report)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Read More